Latest
Featured Content
Bleeding Disorders
Improving the Clinical Diagnosis of Inherited Bleeding Disorders
Many unique challenges surround the diagnosis and treatment of inherited mild bleeding disorders.
Leukemia
Venetoclax, Hypomethylating Agents Are Changing the Treatment Landscape for Acute Myeloid Leukemia
Venetoclax and hypomethylating agents, which both demonstrate single agent activity in acute myeloid leukemia, appear to be more effective when used together.
Hematopoietic Stem Cell Transplantation
Can Modifying Microbial Diversity Change Outcomes Following Allogeneic HSCT?
Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.
ASH 2018
Expert Perspective: The Role of Ibrutinib and Venetoclax in Chronic Lymphocytic Leukemia
Hematology Advisor asked Prithviraj Bose, MD, to discuss the latest research on treatment options for CLL presented at the ASH 2018 Annual Meeting.
Thrombotic Disorders
Updated Clinical Practice Guidelines for Venous Thromboembolism: Pregnant and Pediatric Patients
In this 3-part series, Hematology Advisor spoke with experts about the revisions to the ASH clinical practice guidelines for venous thromboembolism.
